How is Wilson disease diagnosed?

Wilson disease cannot be diagnosed from a single test. The diagnosis is built from a pattern of findings across four pillars, often assembled by a specialist over several clinic visits.¹

1. Serum ceruloplasmin

Ceruloplasmin is the protein that carries copper in the blood. In Wilson disease it is usually low — typically below 20 mg/dL, often below 10 — because the defective ATP7B protein cannot load copper onto ceruloplasmin in the liver.¹²

However, this test has real limitations that are worth knowing about:

• False lows: ceruloplasmin can fall in protein-losing conditions (nephrotic syndrome, severe malnutrition) that have nothing to do with copper.
• False normals: ceruloplasmin is an acute-phase protein, so inflammation, pregnancy, and estrogen use can push it up into the normal range even in someone with Wilson disease.³

A low ceruloplasmin is a strong signal, but a normal result does not rule the disease out.

2. 24-hour urinary copper

A 24-hour urine collection measures how much copper the kidneys are spilling. In untreated Wilson disease this is usually elevated above 100 µg per 24 hours (normal is below 40 µg/24h), reflecting the excess copper the body is attempting to shed.²³

Like ceruloplasmin, this number is not perfectly specific — other liver diseases can also raise urinary copper — so it is one piece of a larger picture rather than a standalone answer.

3. Slit-lamp eye exam for Kayser-Fleischer rings

A specialist ophthalmologist uses a slit lamp to look for a brownish-green ring at the outer edge of the cornea. These rings, called Kayser-Fleischer rings, form when copper deposits in the layers of the cornea.¹

Sensitivity depends heavily on how the disease is presenting:

• Present in nearly all patients with neurological Wilson disease
• Present in roughly half of patients who have liver involvement only
• Occasionally absent even in confirmed cases¹³

The exam must be done by an experienced ophthalmologist — the rings can be subtle and easy to miss without proper equipment and training.

4. Genetic testing — ATP7B

Sequencing the ATP7B gene looks for pathogenic variants that disrupt the copper-transporting protein. When two clear pathogenic variants are found — one on each copy of the gene — the diagnosis is confirmed.¹²

Genetic testing also plays a critical role beyond the patient themselves: once a person is diagnosed, first-degree relatives (siblings in particular) can be tested. Because Wilson disease is recessive, siblings have a one-in-four chance of being affected, often before any symptoms have appeared.

When the picture is unclear

Some patients present with an ambiguous picture — near-normal ceruloplasmin, only one identified ATP7B variant, or atypical clinical features. In those cases, additional tests add important information:

Liver biopsy with quantitative hepatic copper

A liver biopsy measuring the actual copper concentration in liver tissue is among the most direct tests available. A hepatic copper level above 250 µg per gram dry weight is strongly supportive of the diagnosis.⁴ This threshold forms part of the Leipzig scoring system (see below).

Penicillamine challenge test

This test measures how much extra copper is excreted in the urine after giving a dose of D-penicillamine. It has historically been used in children, but its role in adults has narrowed as genetic testing has improved, and its interpretation is contested in modern guidelines.⁵³ If this test is mentioned to you, ask your specialist whether it is the right tool for your specific situation.

MRI of the brain

In patients with neurological symptoms, brain MRI often shows characteristic signal changes in the basal ganglia — the deep brain structures that control movement. A dramatic but recognised imaging pattern is the so-called “face of the giant panda” sign, caused by specific signal changes in the midbrain on T2-weighted images.⁶⁷ MRI findings support the diagnosis and help guide treatment decisions but are not required to establish it.

The Leipzig diagnostic score

The Leipzig scoring system, first published in 2003, brings all of these findings together into a single number.⁴ Points are assigned for low ceruloplasmin, raised urinary copper, Kayser-Fleischer rings, neurological symptoms, hepatic copper on biopsy, and molecular genetic findings. A score of 4 or above confirms the diagnosis; a score of 3 suggests further investigation is needed; a score of 2 or below makes Wilson disease unlikely. Both the EASL and AASLD guidelines endorse its use.²³

The most important next step

If you or a family member has been told Wilson disease is possible but the workup is inconclusive, a referral to a hepatology centre experienced in Wilson disease is the most valuable thing you can arrange. Specialist centres see enough cases to assemble the full picture accurately and to avoid both over-diagnosis and under-diagnosis.

This post is intended for general education and does not constitute medical advice. Please discuss your specific situation, test results, and any treatment decisions with a qualified healthcare professional.

References